Co-Producer
|
|
| JuLY
31, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Gilad Almogy, CEO & Founder, Ultima
Genomics |
In
this Q&A, Almogy explains how the
company's open-flow-cell architecture
enables dramatically lower costs and
higher throughput, describes how those
capabilities are being deployed across
clinical oncology, population genomics,
and large-scale biological AI, and the
challenges that remain. More
|
|
|
|
|
Join
us September 30 – October 1 for
LSPA’s largest partnering event of
the year. Connect with the life
sciences ecosystem throughout the
Commonwealth and beyond, get the
latest information through timely
panel discussions and learn about
the newest innovations shaping the
industry.
|
|
Learn More
→ |
|
|
- IMUNON: Strong Enrollment Momentum in Phase
3 OVATION 3 Trial of IMNN-001 in Advanced
Ovarian Cancer More
- Medicus Pharma: Receives UAE Department of
Health (DOH) Authorization to Proceed With
Novel Prospective Genomics Guided Precision
Medicine Study Evaluating Teverelix in Women
With Endometriosis More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Biocentury: AI Biotechs Punched Above Their
Weight in 1H26 Venture Megarounds More*
- BMS CEO Boerner Doesn't 'Feel Any Compulsion
to Chase Deals' Despite Lack of M&A This
Year More
- Inside the Deal: Passage Bio Weighed 21
Merger Bids Before Choosing Remix More*
- LSN: Hot Investor Mandate (Updated 7/28) More
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Big4Bio CEO Weekly Q&A: Gilad
Almogy, CEO & Founder, Ultima Genomics More
- BioPharmGuy News: Double Team Roast, Actions
and Consequences, Nerds and Rockstars,
OnlyMarms More
- Bristol Myers Delays Cobenfy Alzheimer's
Psychosis Readout Again Amid Another Quarterly
Beat More
- More on Wistar Scientists Identifying New
Mechanism Behind Chemotherapy Resistance in
Ovarian Cancer More
- Penn Medicine: Soluble Signals Released
by Neighboring Cells Direct How the Human
Kidney Is Built More
- Slone Partners: Premier Executive
Search and Talent Advisory Firm More
- SJU Podcast: Path to Commercialization in
Healthcare - Pharma HCP Marketer Paul Marachi
Is Interviewed by Adam Petersen & Jon Evoy
Podcast
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Temple University: Darilyn v. Moyer, MD '85
RES '88 - From Temple Roots to a National
Voice in Medicine More
- The Next Wave of Innovation in Oncology More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- ICYMI: STRATA Skin Sciences Appoints Medical
Device Commercial Leader Erica Jordan as Chief
Executive Officer More
- OPPORTUNITY: Chief Scientific Officer,
Manassas, VA
More
- OPPORTUNITY: President, PA More
- OPPORTUNITY: Vice President, Global BD,
Remote More
- Slone Partners: Places Amer Mirza, PhD, as
Chief Scientific Officer at Prolynx More
- Slone Partners: The Convergence of
MedTech and Digital Health - How New Hybrid
Devices Are Reshaping Care Delivery and
Leadership Profiles More
- The Wistar Institute: Recruits Christopher
McGinnis More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Philadelphia Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Philadelphia,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
